BACH2 Immunodeficiency Illustrates an Association Between Super-enhancers and Haploinsufficiency
Overview
Authors
Affiliations
The transcriptional programs that guide lymphocyte differentiation depend on the precise expression and timing of transcription factors (TFs). The TF BACH2 is essential for T and B lymphocytes and is associated with an archetypal super-enhancer (SE). Single-nucleotide variants in the BACH2 locus are associated with several autoimmune diseases, but BACH2 mutations that cause Mendelian monogenic primary immunodeficiency have not previously been identified. Here we describe a syndrome of BACH2-related immunodeficiency and autoimmunity (BRIDA) that results from BACH2 haploinsufficiency. Affected subjects had lymphocyte-maturation defects that caused immunoglobulin deficiency and intestinal inflammation. The mutations disrupted protein stability by interfering with homodimerization or by causing aggregation. We observed analogous lymphocyte defects in Bach2-heterozygous mice. More generally, we observed that genes that cause monogenic haploinsufficient diseases were substantially enriched for TFs and SE architecture. These findings reveal a previously unrecognized feature of SE architecture in Mendelian diseases of immunity: heterozygous mutations in SE-regulated genes identified by whole-exome/genome sequencing may have greater significance than previously recognized.
Molecular analysis of acute pyelonephritis-excessive innate and attenuated adaptive immunity.
Ambite I, Chao S, Rosenblad T, Hopkins R, Storm P, Ng Y Life Sci Alliance. 2025; 8(3).
PMID: 40036168 PMC: 11662066. DOI: 10.26508/lsa.202402926.
Aissaoui O, Moundir A, Drissi Boughanbour A, El Bakkouri J, Benhsaien I, Ailal F Tunis Med. 2025; 103(1):93-97.
PMID: 39812200 PMC: 11906231. DOI: 10.62438/tunismed.v103i1.5182.
Watanabe-Matsui M, Kadoya S, Segawa K, Shima H, Nakagawa T, Nagasawa Y iScience. 2025; 28(1):111529.
PMID: 39758820 PMC: 11699347. DOI: 10.1016/j.isci.2024.111529.
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.
Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q Signal Transduct Target Ther. 2024; 9(1):340.
PMID: 39627201 PMC: 11615378. DOI: 10.1038/s41392-024-02030-9.
Agrifoglio O, Kasprick A, Gross N, Wahlig M, Kauffold E, Woitas A Biomedicines. 2024; 12(11).
PMID: 39595046 PMC: 11591683. DOI: 10.3390/biomedicines12112480.